Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000225949 | SCV000283919 | likely benign | Gastrointestinal stromal tumor | 2024-01-21 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001014730 | SCV001175477 | likely benign | Hereditary cancer-predisposing syndrome | 2018-11-20 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV004808641 | SCV005434711 | likely benign | not provided | 2024-09-01 | criteria provided, single submitter | clinical testing | KIT: BP4, BP7 |
Prevention |
RCV003897519 | SCV004715569 | likely benign | KIT-related disorder | 2021-12-30 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |